PRINCE PHARM monthly revenue
PRINCE PHARM
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$0.1B | -16.3% | +26.2% | NT$0.6B |
| May 2026 | Jun 17, 2026 | NT$0.1B | +41.9% | +38.6% | NT$0.5B |
| Apr 2026 | May 17, 2026 | NT$0.1B | -20.1% | +19.3% | NT$0.4B |
| Mar 2026 | Apr 17, 2026 | NT$0.1B | +37.7% | +55.8% | NT$0.3B |
| Feb 2026 | Mar 17, 2026 | NT$0.1B | +3.2% | +63.9% | NT$0.2B |
| Jan 2026 | — | NT$0.1B | — | +31.7% | NT$0.1B |
| Dec 2025 | — | NT$0.1B | — | +39.5% | NT$1.1B |
| Nov 2025 | — | NT$0.1B | — | +121.8% | NT$1B |
| Oct 2025 | — | NT$0.1B | — | +74.7% | NT$0.8B |
| Sep 2025 | — | NT$0.1B | — | +90.0% | NT$0.7B |
| Aug 2025 | — | NT$0.1B | — | +51.9% | NT$0.6B |
| Jul 2025 | — | NT$0.1B | — | +80.3% | NT$0.5B |
| Jun 2025 | — | NT$0.1B | — | +31.1% | NT$0.4B |
| May 2025 | — | NT$0.1B | — | +59.2% | NT$0.4B |
| Apr 2025 | — | NT$0.1B | — | +28.4% | NT$0.3B |
| Mar 2025 | — | NT$0.1B | — | +43.0% | NT$0.2B |
| Feb 2025 | — | NT$0.1B | — | +35.5% | NT$0.1B |
| Jan 2025 | — | NT$0.1B | — | -1.4% | NT$0.1B |
| Dec 2024 | — | NT$0.1B | — | -2.4% | NT$0.7B |
| Nov 2024 | — | NT$0.1B | — | -23.9% | NT$0.6B |
| Oct 2024 | — | NT$0.1B | — | +6.7% | NT$0.6B |
| Sep 2024 | — | NT$0.1B | — | -33.0% | NT$0.5B |
| Aug 2024 | — | NT$0.1B | — | -5.1% | NT$0.5B |
| Jul 2024 | — | NT$0.1B | — | -3.6% | NT$0.4B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-03-23. Source: Company websiteTaiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.